13 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33978839 | Autophagy inhibitor potentiates the antitumor efficacy of apatinib in uterine sarcoma by stimulating PI3K/Akt/mTOR pathway. | 2021 Aug | 4 |
2 | 34077013 | Apatinib strengthens the anti-tumor effect of cisplatin in thyroid carcinoma through downregulating VEGFR2. | 2021 Mar-Apr | 4 |
3 | 34229754 | Apatinib induces endoplasmic reticulum stress-mediated apoptosis and autophagy and potentiates cell sensitivity to paclitaxel via the IRE-1α-AKT-mTOR pathway in esophageal squamous cell carcinoma. | 2021 Jul 6 | 4 |
4 | 34249438 | Targeting ERK combined with apatinib may be a promising therapeutic strategy for treating oral squamous cell carcinoma. | 2021 | 2 |
5 | 34868934 | Anti-Tumor Effect of Apatinib and Relevant Mechanisms in Liposarcoma. | 2021 | 2 |
6 | 32126236 | Apatinib exhibits cytotoxicity toward leukemia cells by targeting VEGFR2-mediated prosurvival signaling and angiogenesis. | 2020 May 1 | 1 |
7 | 32209188 | [Apatinib Combined with CCI-779 Inhibits the Proliferation and Migration of Small Cell Lung Cancer NCI-H446 Cells In Vitro]. | 2020 Apr 20 | 2 |
8 | 32219060 | Apatinib Inhibits Cell Proliferation and Induces Autophagy in Human Papillary Thyroid Carcinoma via the PI3K/Akt/mTOR Signaling Pathway. | 2020 | 3 |
9 | 32788939 | Apatinib induces apoptosis and autophagy via the PI3K/AKT/mTOR and MAPK/ERK signaling pathways in neuroblastoma. | 2020 Oct | 2 |
10 | 30863481 | Apatinib Promotes Apoptosis of Pancreatic Cancer Cells through Downregulation of Hypoxia-Inducible Factor-1α and Increased Levels of Reactive Oxygen Species. | 2019 | 1 |
11 | 31079851 | Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2. | 2019 Jul | 1 |
12 | 30301881 | Apatinib-induced protective autophagy and apoptosis through the AKT-mTOR pathway in anaplastic thyroid cancer. | 2018 Oct 9 | 4 |
13 | 29085592 | Apatinib has anti-tumor effects and induces autophagy in colon cancer cells. | 2017 Sep | 1 |